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Background: Experimental autoimmune uveoretinitis (EAU) is a widely used experimental animal model of human
endogenous posterior uveoretinitis. In the present study, we performed in vivo imaging of the retina in transgenic
reporter mice to investigate dynamic changes in exogenous inflammatory cells and endogenous immune cells
during the disease process.
Methods: Transgenic mice (C57Bl/6 J Cx3cr1
GFP/+, C57Bl/6 N CD11c-eYFP, and C57Bl/6 J LysM-eGFP) were used to
visualize the dynamic changes of myeloid-derived cells, putative dendritic cells and neutrophils during EAU.
Transgenic mice were monitored with multi-modal fundus imaging camera over five time points following disease
induction with the retinal auto-antigen, interphotoreceptor retinoid binding protein (IRBP1–20). Disease severity was
quantified with both clinical and histopathological grading.
Results: In the normal C57Bl/6 J Cx3cr1
GFP/+ mouse Cx3cr1-expressing microglia were evenly distributed in the retina.
In C57Bl/6 N CD11c-eYFP mice clusters of CD11c-expressing cells were noted in the retina and in C57Bl/6 J LysM-eGFP
mice very low numbers of LysM-expressing neutrophils were observed in the fundus. Following immunization with
IRBP1–20, fundus examination revealed accumulations of Cx3cr1-GFP
+ myeloid cells, CD11c-eYFP+ cells and LysM-eGFP+
myelomonocytic cells around the optic nerve head and along retinal vessels as early as day 14 post-immunization.
CD11c-eYFP+ cells appear to resolve marginally earlier (day 21 post-immunization) than Cx3cr1-GFP
+ and LysM-eGFP+
cells. The clinical grading of EAU in transgenic mice correlated closely with histopathological grading.
Conclusions: These results illustrate that in vivo fundus imaging of transgenic reporter mice allows direct visualization
of various exogenously and endogenously derived leukocyte types during EAU progression. This approach acts as a
valuable adjunct to other methods of studying the clinical course of EAU.
Keywords: Experimental autoimmune uveoretinitis, Reporter mice, Clinical imaging, Retinal inflammation, Microglia,
Neutrophils, Dendritic cells* Correspondence: paul.mcmenamin@monash.edu
1Department of Anatomy and Developmental Biology, School of Biomedical
Sciences, Faculty of Medicine, Nursing and Health Sciences, Monash
University, Clayton, Victoria, Australia
Full list of author information is available at the end of the article
© 2015 Chen et al.; licensee BioMed Central. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article,
unless otherwise stated.
Chen et al. Journal of Neuroinflammation  (2015) 12:17 Page 2 of 12Introduction
Uveitis is the fourth leading cause of blindness in the
working age population in developed countries [1,2].
Endogenous posterior uveoretinitis makes up 22% of uve-
itis cases [3]. The aetiology of non-infectious uveoretinitis
is unknown in most cases and has been considered to
have an autoimmune basis [4,5]. Well-established animal
models of experimental autoimmune uveoretinitis have
provided a valuable experimental platform for improving
our understanding of the disease pathogenesis and mecha-
nisms of autoimmune uveoretinitis [4-8].
Experimental autoimmune uveoretinitis (EAU) is an
organ-specific, T-cell mediated disease that can be induced
in susceptible mouse strains by direct immunization with
retinal antigens, including interphotoreceptor retinoid
binding protein (IRBP) or arrestin (retinal soluble antigen,
S-antigen), in complete Freund’s adjuvant and a simul-
taneous intraperitoneal injection of pertussis toxin.
Alternatively, EAU can be induced indirectly by adop-
tive transfer of retinal antigen-specific effector T cells
[4]. Disease usually develops around 10 to 14 days after
immunization and is clinically evident within the retina
as inflammatory cell infiltration which will include
macrophages [9], dendritic cells (DCs) [10], neutrophils
[11] and T cells [9,11]. In addition to the influx of
blood-derived leukocytes, the resident myeloid-derived
macrophages, retinal microglia, are also activated during
EAU [7,8].
The Cx3cr1
gfp/+ transgenic knock-in mouse [12] has
enabled exquisite in vivo and ex vivo visualization of the
dynamic changes in microglia in steady and diseased
states in the eye [13-17], as well as in the brain [18,19],
and in particular their rapid responsiveness to injury
and presence of noxious stimuli [14,15]. The study of
Cx3cr1-bearing brain microglia in vivo in these reporter
mice requires the surgical creation of a defect or window
in the calvaria and two-photon microscopic examination
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DC, dendritic cell; GFP, green fluorescent protein; eGFP, enhanced green fluorescenunique advantages for direct in vivo visualization of infil-
trating and resident immune cells in reporter mice with
minimal experimental manipulation [16,21-23]. However,
to date there has been limited use of reporter mice to
investigate the dynamics of infiltrating leukocytes and resi-
dent myeloid cells in an ocular model of autoimmunity.
In the present study, we demonstrate that in vivo fundus
examination of transgenic reporter mice facilitates moni-
toring of the dynamic changes in various exogenously and
endogenously derived cells of myeloid lineage during EAU
progression. In particular we chose to examine EAU in
transgenic mice (C57Bl/6 J Cx3cr1
GFP/+, C57Bl/6 CD11c-
eYFP, and C57Bl/6 J LysM-eGFP) in which promoter
elements of the myeloid-specific Cx3cr1, CD11c and lysM
genes are expressed alongside a specific fluorescent re-
porter in an attempt to characterize the relative temporal
pattern of resident and infiltrating myeloid cells, DCs, and
neutrophils, respectively. Whilst we appreciate that none
of these transgenic reporter mice provide definitive identi-
fication of any of the above myeloid cell subsets and thus
have their limitations [24], our results do provide novel
insights into the cell mediated immune events in this
model of human endogenous posterior uveoretinitis and
allow accurate clinical grading of disease severity that
correlates with histopathological changes.
Materials and methods
Mice
Transgenic reporter mice in which the myeloid-specific
promoter of the Cx3cr1, CD11c, and lysM genes drives the
expression of fluorescent reporters (C57Bl/6 J Cx3cr1
GFP/+,
C57Bl/6 N CD11c-eYFP, and C57Bl/6 J LysM-eGFP mice,
respectively) were used in this study at an age of between 8
and 10 weeks. The details of the myeloid promoter and
reporter mice used in this study are summarized in Table 1.
C57Bl/6 J Cx3cr1
GFP/+ mice were created by crossing
homozygous C57Bl/6 J Cx3cr1
GFP/GFP mice, originally
obtained from Professor Steffen Jung [12], to wild-typeResearch use
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enhanced yellow fluorescent protein (eYFP) under the
promoter for the Itgax (CD11c) gene and are widely
regarded as a valuable model for investigating the dis-
tribution of DCs with the caveat that other cells are
capable of limited expression of CD11c [25]. C57Bl/6 N
CD11c-eYFP breeding pairs were kindly provided by
Associate Professor Michael Hickey (Monash University,
Clayton, VIC, Australia) with permission from Professor
Michel Nussenzweig (The Rockefeller University, New
York, NY, USA) from whom the original mice were
obtained [25]. C57Bl/6 J Cx3cr1
GFP/+ and C57Bl/6 CD11c-
eYFP mice were bred at the Monash Large Animal Facility
(Monash University). C57Bl/6 J LysM-eGFP mice were
kindly provided by Associate Professor Michael Hickey.
C57Bl/6 J LysM-eGFP mice were created by cloning en-
hanced green fluorescent protein (eGFP) into the lysozyme
M (LysM) locus where LysM is expressed in myelomonoy-
tic cells (macrophages and neutrophil granulocytes) [26].
C57Bl/6 J Cx3cr1
GFP/+ and C57Bl/6 J LysM-eGFPmice were
screened by PCR [22] and determined to be negative for
retinal degeneration 8 (rd8) mutation in the crumbs 1
(Crb1) gene (data not shown). C57Bl/6 N CD11c-eYFP
mice were found to carry the rd8 mutation and this has
been described in detail elsewhere [22]. All experimental
animals were maintained under 12:12-hour light/dark cycle
with ad libitum access to food and water. All procedures in
this study were approved by the Monash Animal Ethics
Committee (MARP/2011/094) and were performed in
accordance with the ARVO Statement for the Use of
Animals in Ophthalmic and Vision Research.
Induction of experimental autoimmune uveoretinitis
EAU was induced using a standard protocol, previously
described by others [8]. Briefly mice received a sub-
cutaneous (s.c.) injection of a total of 100 μl emulsion,
containing a 50:50 mix of 400 μg human IRBP peptide
1–20 (IRBP1–20; GPTHLFQPSLVLDMAKVLLD; China
Peptides, Shanghai, China) in complete Freund’s adjuvant
(CFA; Sigma-Aldrich, St Louis, MO, USA) supplemented
with Mycobacterium tuberculosis H37RA (2.5 mg/ml; BD
PharMingen, San Diego, CA, USA), distributed between
the base of the tail and the right flank of each mouse. Mice
simultaneously received an intraperitoneal (i.p.) injection
of 1.5 μg pertussis toxin (Sigma-Aldrich) in phosphate-
buffered saline (PBS). Control mice received s.c. injection
of a total of 100 μl emulsion containing 50:50 mixture of
CFA and PBS (no IRBP) and i.p. injection of pertussis
toxin.
Clinical examination of eyes
Mice were clinically examined on day (d) 0, 14, 21, 28 and
35 post-immunization (p.i.). Mice were anesthetized by an
i.p. injection of a mixture of ketamine (80 mg/kg; TroyLaboratories, Glendenning, NSW, Australia) and xylazine
(10 mg/kg; Troy Laboratories). The pupils were dilated
with 0.5% tropicamide (Mydriacil, Alcon Laboratories,
Vilvoorde, Belgium), and the cornea was kept moist with
the application of sterile lubricant GenTeal gel (Novartis,
North Ryde, NSW, Australia). The fundus was examined
using the Micron III camera (Phoenix Research Labora-
tories, Pleasanton, CA, USA) with StreamPix 5 software.
Examination consisted firstly of capturing short 5 seconds
videos with 100 frames in brightfield, followed by a se-
quence of GFP+ or YFP+ cells using the green fluorescent
barrier filters, and lastly by a short sequence following a
20 μl s.c. injection of 10% fluorescein isothiocyanate
(Alcon Laboratories, Frenchs Forest, NSW, Australia)
to visualize the retinal vasculature. The brightness and
contrast of all fundus images were adjusted equally
using ImageJ 1.48C software [27].
Clinical assessment of experimental autoimmune
uveoretinitis
The severity of disease was graded based on examination
of the three modes of clinical fundus images (brightfield,
fluorescent, and fluorescein angiography) by two masked
observers using a modification of a previously described
clinical grading scheme for EAU [6]. The modifications
to the grading criteria (Table 2) were primarily a conse-
quence of having both traditional brightfield fundus
views augmented by the fluorescent capability offered by
the Micron III camera.
Histological assessment of experimental autoimmune
uveoretinitis
Mice were euthanized on d35 p.i. with an i.p. injection
of sodium pentabarbitone (Lethabarb; Virbac, Milperra,
NSW, Australia) and were perfused with 1% heparin in
PBS followed by 4% paraformaldehyde (PFA) in PBS. Eyes
were enucleated and stored in 4% PFA at 4°C. The right eye
from each animal was post-fixed with Karnovsky fixative
(4% PFA: 1% glutaraldehyde) for 48 hours and processed
for resin histology. Tissues were embedded in Technovit
glycol methacrylate resin (Heraeus Kulzer, Wehrheim,
Germany), sectioned at 5 μm thickness through the optic
nerve-pupillary axis and stained with haematoxylin and
eosin. Sections from three different levels of each eye
separated by a minimum distance of 50 μm were exam-
ined by light microscopy and disease severity was scored
by a masked observer using the previously published
histopathology grading system for mouse EAU [28].
Results
Imaging of experimental autoimmune uveoretinitis
disease progression in C57Bl/6 J Cx3cr1
GFP/+ mice
In vivo clinical examination of eyes in C57Bl/6 J Cx3cr1
GFP/+
mice prior to immunization revealed a normal fundus using
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distribution of the retinal microglia network in green
fluorescent mode (Figure 1B) and normal retinal vascula-
ture following fluorescein angiography (FA; Figure 1C).
The time course of EAU was monitored in C57Bl/6 J
Cx3cr1
GFP/+ mice immunized with IRBP1–20 over four
time points (d14, d21, d28, and d35 p.i.). EAU disease was
first observed on d14 p.i. (Figure 1D-F), was maximal at
d21 p.i. (Figure 1G-I) and d28 p.i. (Figure 1J-L), and was
only slightly reduced in severity at d35 p.i. (Figure 1M-O).
All IRBP1–20 immunized mice developed EAU while adju-
vant treated control mice appeared normal at all time
points (Additional file 1: Figure S1A-C).
Clinical examination of C57Bl/6 J Cx3cr1
GFP/+ mice during
experimental autoimmune uveoretinitis reveals different
disease severities
EAU disease severity can vary in IRBP1–20 immunized
C57Bl/6 J Cx3cr1
GFP/+ mice from mild (Additional file 1:
Figure S1D-F), moderate (Additional file 1: Figure S1G-I)
to severe (Additional file 1: Figure S1J-L) at all time
points. Mild disease is characterized by swelling of the
optic nerve head and mild vasculitis or perivenular cuffing
(Additional file 1: Figure S1D), both evident due to accu-
mulations of Cx3cr1-GFP
+ myeloid cells (Additional file 1:
Figure S1E). However, no fluorescein leakage was noted
in FA at this point although only the early filling phase
was examined (Additional file 1: Figure S1F). Moderate
grades are characterised by multiple small focal retinal
lesions with moderate vasculitis affecting all retinal ves-
sels evident in brightfield (Additional file 1: Figure S1G)
and as Cx3cr1-GFP
+ perivenular infiltrates (Additional
file 1: Figure S1H) with an absence of fluorescein leakage
(Additional file 1: Figure S1I). Despite the presence of
Cx3cr1-GFP
+ perivenular infiltrates, Cx3cr1-GFP
+ cellular
infiltrates were absent in some focal retinal lesions seen in
brightfield (Additional file 1: Figure S1G). Severe EAU can
occasionally be detected as early as d14 p.i. and in the eyeswhere EAU disease was seen to be severe, multiple large
retinal lesions and vasculitis affecting all retinal veins
was noted (Additional file 1: Figure S1J). Marked Cx3cr1-
GPF+ peri-vascular infiltrates (Additional file 1: Figure
S1K) sometimes correlated with leakage of fluorescein
(Additional file 1: Figure S1L). The short 5 second
brightfield fundus video also demonstrated rolling and
migration of Cx3cr1-GFP
+ cells and non-Cx3cr1-GFP
+
cells in the retinal veins (Additional file 2: Supplementary
video 1).
To eliminate the possibility that the hyperfluorescent
perivascular infiltrates in C57Bl/6 J Cx3cr1
GFP/+ mice are
due to autofluorescence inflammatory cells we have pro-
vided clinical fundus images of IRBP1–20 immunized
Wildtype C57Bl/6 J taken at d21 p.i. (Additional file 3:
Figure S2).
Clinical grading strongly correlates with histopathological
grade of experimental autoimmune uveoretinitis disease
in C57Bl/6 J Cx3cr1
GFP/+ mice at day 35 post-immunization
EAU clinical disease scores from all clinical imaging time
points were determined by two masked observers using the
grading criteria (Table 2). All adjuvant controls appeared
normal at all time points (Figure 2A) and no histopatho-
logical changes were observed at d35 p.i. (Figure 2C). In
IRBP1–20 immunized C57Bl/6 J Cx3cr1
GFP/+ mice EAU
began to develop around d14 p.i. with grade 1.86 ± 0.33
(mean ± SEM) disease then gradually progressed over time
and remained at grade 2.81 ± 0.24 until d35 p.i. (Figure 2A).
Histopathological disease scores in C57Bl/6 J Cx3cr1
GFP/+
mice at d35 p.i. revealed a mean infiltrative grade of
2.38 ± 0.60 and a structural grade of 2.00 ± 0.38. Total
histopathological score shows a significant positive
correlation (r = 0.73; P = 0.019) with the clinical scores
(Figure 2B). C57Bl/6 J Cx3cr1
GFP/+ mice immunized
with IRBP1–20 displayed classical histopathological fea-
tures of EAU (Figure 2D-F), which have been described
previously by several authors [6,28-30].
Figure 1 Time-course monitoring of experimental autoimmune uveoretinitis disease with multi-modal imaging in one representative
C57Bl/6 J Cx3cr1
GFP/+ mouse. Fundus images of a C57Bl/6 J Cx3cr1
GFP/+ mouse immunized with IRBP1–20 in brightfield (BF) (A,D,G,J,M), fluorescent
(Fluor) (B,E,H,K,N), and fluorescein angiography (FA) (C,F,I,L,O) taken over five time points illustrated experimental autoimmune uveoretinitis disease
progression and GFP+ myeloid cell perivascular infiltrates during disease progression. d, Day; p.i. post-immunization. GFP, green fluorescent protein;
IRBP, interphotoreceptor retinoid binding protein.
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uveoretinitis in C57Bl/6 N CD11c-eYFP mice
The C57Bl/6 N CD11c-eYFP mouse has been extensively
used to map putative DCs in a variety of tissues [25,31-36].
We have recently described our discovery of the presence
of the rd8 mutation in the Crb1 gene in the C57Bl/6 N
CD11c-eYFP mice [22]. Multiple retinal lesions (Figure 3A)
were observed in the fundus of naïve C57Bl/6 N CD11c-
eYFP mice and we illustrated that these lesions co-localizedwith CD11c-eYFP+ cells (Figure 3B) [22]. At the time of
our experiments to investigate the course of EAU in
C57Bl/6 N CD11c-eYFP mice we were unaware of the rd8
mutation. It was during clinical examination of d0 naïve
animals that we became suspicious of a baseline patho-
logical status. Despite the presence of retinal degeneration,
EAU was readily induced and typical EAU changes were
noted in C57Bl/6 N CD11c-eYFP mice on d14 and d21 p.i.
By d14 p.i. severe vasculitis was seen on brightfield
Figure 2 Comparison of experimental autoimmune uveoretinitis clinical and histopathological score in C57Bl/6 J Cx3cr1
GFP/+ mice.
No adjuvant controls developed experimental autoimmune uveoretinitis (EAU). EAU clinical disease score (A) in C57Bl/6 J Cx3cr1
GFP/+ mice
revealed a grade 2.8 disease by day 35 (d35) post-immunization (p.i.) (adjuvant controls: d0, d14, and d28: n = 14, d21 and 35: n = 24; IRBP1–20: d0:
n = 33, d14: n = 24, d21: n = 32, d28: n = 20, d35: n = 28). (B) Correlation between total histopathological disease score in C57Bl/6 J Cx3cr1
GFP/+ mice
on d35 p.i. and the clinical grade in the same mice (IRBP1–20: n = 8). Pearson’s correlation was applied to analyse the correlation and the correlation
coefficient (r) illustrate a strong positive linear correlation that is significant, P < 0.05. (C) Histology demonstrated no pathology in adjuvant controls.
Representative histology images from C57Bl/6 J Cx3cr1
GFP/+ mice immunized with IRBP1-20 illustrate key histopathological features of EAU including
vasculitis (D; arrows), granuloma (D; arrowhead), retinal folds (E; arrows), vitritis (E; arrowheads), loss of retinal outer nuclear layer and photoreceptor
layer (F; arrow), and cellular infiltrates of the retinal pigment epithelium and choroid (F; arrowheads). IRBP, interphotoreceptor retinoid binding protein.
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CD11c-eYFP+ cells along retinal veins was observed in
the fluorescent mode (Figure 3D) as well as in the
brightfield due to the strong eYFP signal. Clinical exam-
ination on d21 p.i. revealed that vasculitis and the large
influx of CD11c-eYFP+ cells was partly resolved but
multiple retinal lesions were still present, and CD11c-
eYFP+ cells were more evenly distributed in the retina
(Figure 3E,F). FA examination revealed absence of fluores-
cein leakage (data not shown). All IRBP1–20 immunizedmice developed EAU while adjuvant treated control mice
appeared normal at all time points.
Visualization of LysM-eGFP+ myelomonocytic cell infiltration
during experimental autoimmune uveoretinitis in C57Bl/6 J
LysM-eGFP mice
In C57Bl/6 J LysM-eGFP mice, eGFP is cloned into the
LysM locus which is expressed in myelomonocytic cells
(macrophages-eGFPlow and neutrophils-eGFPhigh) [26] and
have been used for in vivo imaging of neutrophils in healthy
Figure 3 Clinical fundus examination of C57Bl/6 N CD11c-eYFP mice in normal and diseased state. Fundus images of naïve C57Bl/6
N CD11c-eYFP (Crb1rd8) mice in brightfield (BF) (A) and fluorescent mode (Fluor) (B) displaying multiple retinal lesions and accumulation of
CD11c-eYFP+ cells in the retinal lesions attributable to the rd8 mutation. Fundus images of C57Bl/6 N CD11c-eYFP mice (n = 10) immunized with
IRBP1–20 on day 14 post-immunization (d14 p.i.) (C-D) and d21 p.i. (E-F) demonstrated perivascular infiltrates. eYFP, enhanced yellow fluorescent
protein; rd8, retinal degeneration 8.
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C57Bl/6 J LysM-eGFP mouse fundus (n = 5) revealed a
normal appearance (Figure 4A) and genotyping of these
mice demonstrated that they did not carry the rd8 muta-
tion (data not shown). In the naïve retina of these mice
there were 16.6 ± 1.18 (mean ± SEM) LysM-eGFP+ cells
present in the entire normal fundus (Figure 4B). However,
upon examination of the clinical fundus video, transient
LysM-eGFP+ cells were observed travelling at high vel-
ocity through the lumina of the retinal vessels (Additional
file 4: Supplementary video 2). In vivo imaging of IRBP1–20
immunized C57Bl/6 J LysM-eGFP mouse fundus on d14
p.i. illustrated mild EAU with swelling of the optic nerve
head, mild vasculitis (Figure 4C) and accumulations of the
LysM-eGFP+ cells around the optic nerve head and along
the retinal vessels (Figure 4D). Clinical fundus examin-
ation on d21 p.i. revealed multiple large retinal lesions and
moderate vasculitis (Figure 4E) and the LysM-eGFP+ cells
were found along the retinal vessels and in retinal lesions(Figure 4F). FA examination revealed absence of fluores-
cein leakage (data not shown). All IRBP1–20 immunized
mice developed EAU while adjuvant treated control mice
appeared normal at all time points.
Discussion
Intravital imaging using genetically modified reporter mice
in which leukocyte subtypes are endogenously labelled
with a fluorescent reporter gene transcript has greatly
enhanced our understanding of cellular and immuno-
logical mechanisms during inflammation of several tissues
[38-40]. Many of these experimental approaches are partly
hindered or complicated by the potential effects of surgi-
cal intervention needed to exteriorise or surgically alter
the tissue under investigation such as mesentery [41,42],
cremaster muscle [42-44], liver [45], lung [37], kidney
[40,43], and skin [46]. In the case of intravital imaging of
the brain a craniotomy window is required [47,48]. The
eye has several advantages over most organs because by
Figure 4 Clinical fundus examination of C57Bl/6 J LysM-eGFP mice in normal and diseased state. Fundus images of naïve C57Bl/6 J LysM-eGFP
mouse fundus in brightfield (BF) (A) and fluorescent mode (Fluor) (B) appears normal (n =5). Fundus images of C57Bl/6 J LysM-eGFP mouse (n = 4)
immunized with IRBP1–20 on day 14 post-immunization (d14 p.i.) (C-D) and d21 p.i. (E-F) illustrated the peripapillary infiltrates of vasculitis. eGFP,
enhanced green fluorescent protein.
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both neural tissue (retina) and connective tissues (cornea,
iris) [33,49], thus avoiding surgical intervention. We sought
to exploit the recent development of multi-modal imaging
techniques which allow high-quality examination of the
mouse fundus [16,22] to investigate the behaviour of cells
of myeloid origin during the course of EAU, a widely used
model of ocular autoimmune disease.
Disease severity of EAU is routinely determined using
histopathological grading methods [28,29,50]. To circum-
vent the issue of single time point post-mortem grading,
several research groups have developed non-invasive clin-
ical grading methods including topical endoscopic fundus
imaging [51], otoscope imaging [6], scanning laser oph-
thalmoscopy [52] and optical coherence tomography
[53-55]. In this present study, multi-modal fundus oph-
thalmoscopy was chosen to grade the disease severity as
it has the advantages of being relatively inexpensive and
has the capability of capturing both video and still frameimages in brightfield, together with green and red fluor-
escence wavelengths.
Many previous phenotypic analyses of the inflammatory
cell infiltrate during EAU have used multi-parameter flow
cytometry to show that the majority of infiltrating cells are
myeloid-derived with a peak in T cell infiltration around
d14 p.i. [11,56,57]. Alternative approaches to visualize
leukocyte trafficking in vivo in the eye during EAU have
included use of acridine orange, a non-specific nuclear
dye which can be visualized by fluorography. This method
revealed leukocytes rolling along the retinal veins as early
as d14 p.i. [58,59]; however, their specific phenotype
was obviously not determined. More recently, in vivo
imaging of the leukocyte subtypes with more specificity
has become easier with the availability of genetically modi-
fied mouse models in which genes regulating leukocyte
subtypes are used as promoters to express fluorescent
reporter proteins. Although these transgenic mouse models
are useful for providing insights to myeloid lineage cell
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warned of cautious interpretation of these mice as the
sole means of identifying and distinguishing macrophages
and DCs [24]. Such limitations are also true of the three
transgenic mouse lines chosen for the present study.
There are several subpopulations of Cx3cr1-GFP
+
myeloid-derived cells in the normal retina including
the hyalocytes on the retinal surface [60], subretinal
macrophages on the other aspect of the neural retinal
[61-63], and the extensive network of microglial popu-
lations in the retinal parenchyma [13,64]. C57Bl/6 J
Cx3cr1
GFP/+ mice [12] have been widely used to investigate
the role of microglia in numerous ocular conditions that
may have an inflammatory element in their pathogenesis
including potential models of retinal degeneration [65],
retinopathy of prematurity [66,67] and diabetic retinop-
athy [16]. In the present study we demonstrate highly
distinctive perivenular infiltrates of Cx3cr1-GFP
+ cells at
d14 p.i. to d35 p.i. which is in agreement with previous
studies [8,68]. The perivenular infiltrate could theoretically
represent haematogenous Cx3cr1-GPF
+ (GFPlow) myeloid
cells recently extravasated into the retina or the chemotac-
tic migration of resident Cx3cr1-GPF
+ (GFPhigh) microglia
towards the vasculature. We believe the former is the case
as the Cx3cr1-GPF
+ (GFPhigh) microglia network seemed
largely undisturbed, something that was subsequently
confirmed by retinal whole mount analysis (data not
shown).
The difficulty in distinguishing subpopulations of macro-
phages from cells of DC lineage was the motivation for the
creation of CD11c transgenic reporter mice, specifically the
CD11c-eYFP [25] and CD11c-DTR/GFP mice [69]. In these
transgenic mice the promoter for the Itgax (CD11c) gene is
used to drive eYFP expression (CD11c-eYFP mice) or GFP
and diphtheria toxin receptor (DTR) expression (CD11c-
DTR/GFP mice). CD11c is a leukocyte integrin comprised
of an alpha X subunit that along with CD18, a leukocyte
beta 2 integrin polypeptide, forms the CD11c/CD18 hetero-
dimer which is important in leukocyte adhesion, migration
and cell to cell interaction during immune responses.
CD11c is expressed heterogeneously by different popula-
tions of DCs [25] and is important in T cell priming [69].
However, it is also expressed to at least one log lower than
DCs on other immune cells such as natural killer cells,
subpopulations of macrophages and activated T cells [25].
As such immune cells are not normally a feature of the
resting central nervous system, we, like other previous
investigators [31,32,70], thought is reasonably safe to
assume that in the resting and disease state CD11c-eYFP+
cells may represent predominantly DCs. The view that
CD11c-eYFP mice are valuable for examining the distribu-
tion of DCs has recently been strongly challenged by
Hume [24] who points out that CD11c has no function in
antigen presentation; not all DCs are CD11c+ and that notall CD11c+ cells are antigen-presenting cells. It was thus
with caution that we chose to take advantage of the
transgenic C57Bl/6 N CD11c-eYFP mice to examine the
dynamic of DCs in EAU. Indeed at the commencement of
this study we had the further complication of discovering
that these mice had a pre-existing retinal dystrophy due to
the presence of the rd8 mutation in the crb1 gene [71] and
that the CD11c-eYFP+ cells in the retina represented acti-
vated microglia [22]. In the present study, CD11c-eYFP+
cells were recruited into the eye at d14 and d21 p.i. in a
similar pattern to that observed in C57Bl/6 J Cx3cr1
GFP/+
mice leading us to conclude that these CD11c-eYFP+ cells
are likely a mixture of myeloid-derived cells.
Interestingly, despite the C57Bl/6 N CD11c-eYFP mice
carrying the rd8 mutation and the pre-existing disrupted
retinal architecture prior to immunization, they did not
develop a more severe form of EAU as may have been
predicted if one were to assume that this dystrophic
condition compromised the immune status of the retina
as we have previously concluded [22], although we have
not specifically proven that the blood-ocular barrier was
compromised.
In the C57Bl/6 J LysM-eGFP mouse line generated by
Faust and colleagues [26], homologous recombination was
used to insert the eGFP gene into the LysM locus. This
was chosen because LysM is expressed specifically in the
myelomonocytic cell lineage (macrophages and neutrophil
granulocytes). Characterization of LysM-eGFP+ cells in
the blood revealed that the eGFPhigh polymorphonuclear
granulocytes outnumbered LysM-eGFP+ monocytes by
50:1. In the present study, we observed exceedingly small
numbers (16.6 ± 1.18) of largely static LysM-eGFP+ myelo-
monocytic cells around the optic nerve head in the normal
C57Bl/6 J LysM-eGFP fundus. We propose that these are
likely of monocyte lineage as it is highly unusual to detect
extravasated neutophils in the normal retina. However,
video analysis (not shown) revealed many LysM-eGFP+
travelling at high velocity in retinal vessel lumina, which
we conclude are likely to be circulating neutrophils. In
these mice we demonstrated increased numbers of
LysM-eGFP+ cells in the peripapillary retinal vessels at
d14 to d21 of EAU. Closer examination of the high
power images (see inset, Figure 4) suggests that many
of these are marginating in vessel lumina, a pattern
which differs from the perivascular infiltrates observed
in the C57Bl/6 J Cx3cr1
GFP/+ and C57Bl/6 N CD11c-eYFP
mice. Subsequent flow cytometry of retinal tissue during
EAU in C57Bl/6 J LysM-eGFP mice revealed these cells
to be largely a neutrophilic infiltrate (Goldberg and col-
leagues, unpublished data).
Conclusions
In conclusion, in vivo fundus imaging of C57Bl/6 J
Cx3cr1
GFP/+ and C57Bl/6 N CD11c-eYFP mice revealed
Chen et al. Journal of Neuroinflammation  (2015) 12:17 Page 10 of 12the dynamics of the myeloid cell infiltrates in EAU,
particularly the perivenular accumulations. In contrast,
the C57Bl/6 J LysM-eGFP mice revealed intravascular
margination of LysM-eGFPhi neutrophils as well as less
distinctive perivascular infiltrates. The grading of disease
using in vivo imaging of these genetically modified
reporter mice correlated strongly with the histopatho-
logical changes.
Additional files
Additional file 1: Figure S1. Clinical appearance of C57Bl/6 J Cx3cr1
GFP/+
mouse fundus with different severities of EAU. Fundus images of adjuvant
control C57Bl/6 J Cx3cr1
GFP/+ mouse in brightfield (A), fluorescent mode (B),
and fluorescein angiography (C) revealed normal retinal vasculature with
no fluorescein leakage and normal retinal microglia network. Multi-modal
fundus images from C57Bl/6 J Cx3cr1
GFP/+ mice immunized with IRBP1–20
displaying mild (D-F), moderate EAU (G-I), and severe (J-L) EAU. The classical
features of EAU include perivascular vasculitis (D and J, arrows) that is
associated with GFP+ perivascular infiltrates (E and K, arrows) and
multiple focal retinal lesions (G, arrows), venular dilation (L, arrows),
and fluorescein leakage (L, arrowhead).
Additional file 2: Supplementary Video 1. Video of real time in vivo
visualization of rolling leukocytes in retinal veins of C57Bl/6 J Cx3cr1
GFP/+
mouse during EAU. Duration: 5 seconds (20 frames per second).
Additional file 3: Figure S2. Clinical appearance of immunized with
IRBP1–20 WT C57Bl/6 J mouse fundus on d21 p.i. These fundus images of WT
controls in brightfield (A), fluorescent mode (B), and fluorescein angiography
(C) revealed that the inflammatory infiltrated did not autofluoresce.
Additional file 4: Supplementary Video 2. Video of real time in vivo
visualization of naïve C57Bl/6 J LysM-eGFP mouse fundus revealed static
and circulating LysM-eGFP+ myelomonocytic cells. Duration: 5 seconds
(20 frames per second).
Abbreviations
CFA: complete Freund’s adjuvant; Crb1: crumbs 1; d: day; DC: dendritic cell;
DTR: diphtheria toxin receptor; EAU: experimental autoimmune uveoretinitis;
eGFP: enhanced green fluorescent protein; eYFP: enhanced yellow fluorescent
protein; FA: fluorescein angiography; i.p.: intraperitoneal; IRBP: interphotoreceptor
retinoid binding protein; LysM: lysozyme M; PBS: phosphate-buffered saline;
PCR: polymerase chain reaction; PFA: paraformaldehyde; p.i.: post-immunization;
rd8: retinal degeneration 8; s.c.: subcutaneous.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
XC performed the immunization, in vivo analysis, tissue collection and
subsequent histology, and drafted the manuscript. JMK was part supervisor
of XC during her PhD studies and helped plan the study. JVF and CCB were
also part supervisors of XC and advised on the experimental approach and
reviewed the manuscript. GLG and IPW provided data from the C57Bl/6 J
LysM-eGFP mice. PGM is the principle chief investigator in whose laboratory
the studies were performed, and was primarily responsible with XC for the
clinical grading, data analysis, data interpretation and writing of the
manuscript. All authors read and approved the final manuscript.
Acknowledgements
The authors would like to acknowledge Ms Katherine Lim and Dr Jimmy Leong
(Monash University, Clayton, VIC, Australia) for masking the clinical fundus images
and histological slides for disease grading, and Ms Manpreet Sidhu (Monash
University) for assisting with the fundus imaging. The C57Bl/6 CD11c-eYFP and
C57Bl/6 J LysM-eGFP mice were kindly provided by Associate Professor Michael
Hickey. XC is a recipient of National Health and Medical Research Council
(NH&MRC) Dora Lush Biomedical postgraduate scholarship (1039575). GLG is a
recipient of the NH&MRC Career Development Fellowship (1034598). CCB issupported by grants from the NH&MRC (1053621), the Victoria/CIRM Joint Project
(RMI-01739) and the Department of Industry (AISRF06680), Commonwealth of
Australia. PGMcM receives support from the NH&MRC (1069979).
Author details
1Department of Anatomy and Developmental Biology, School of Biomedical
Sciences, Faculty of Medicine, Nursing and Health Sciences, Monash
University, Clayton, Victoria, Australia. 2Section of Immunology and Infection,
Division of Applied Medicine, School of Medicine and Dentistry, Institute of
Medical Science, Foresterhill, University of Aberdeen, Scotland, UK. 3Ocular
Immunology Program, Centre for Ophthalmology and Visual Science, The
University of Western Australia, Crawley, Western Australia, Australia. 4Centre
for Experimental Immunology, Lions Eye Institute, Nedlands, Crawley,
Western Australia, Australia. 5Walter and Eliza Hall Institute of Medical
Research, Parkville, Victoria, Australia. 6Australian Regenerative Medicine
Institute, Monash University, Clayton, Victoria, Australia.
Received: 29 October 2014 Accepted: 5 January 2015
References
1. Durrani OM, Meads CA, Murray PI. Uveitis: a potentially blinding disease.
Ophthalmologica. 2004;218:223–36.
2. Suttorp-Schulten MS, Rothova A. The possible impact of uveitis in blindness:
a literature survey. Br J Ophthalmol. 1996;80:844–8.
3. Rothova A, Suttorp-van Schulten MS, Frits Treffers W, Kijlstra A. Causes and
frequency of blindness in patients with intraocular inflammatory disease. Br
J Ophthalmol. 1996;80:332–6.
4. Caspi RR. A look at autoimmunity and inflammation in the eye. J Clin Invest.
2010;120:3073–83.
5. Forrester JV. Endogenous posterior uveitis. Br J Ophthalmol. 1990;74:620–3.
6. Xu H, Koch P, Chen M, Lau A, Reid DM, Forrester JV. A clinical grading system
for retinal inflammation in the chronic model of experimental autoimmune
uveoretinitis using digital fundus images. Exp Eye Res. 2008;87:319–26.
7. Rao NA, Kimoto T, Zamir E, Giri R, Wang R, Ito S, et al. Pathogenic role of
retinal microglia in experimental uveoretinitis. Invest Ophthalmol Vis Sci.
2003;44:22–31.
8. Kezic J, McMenamin PG. The monocyte chemokine receptor CX3CR1 does
not play a significant role in the pathogenesis of experimental autoimmune
uveoretinitis. Invest Ophthalmol Vis Sci. 2010;51:5121–7.
9. Chan C-C, Li Q. Immunopathology of uveitis. Br J Ophthalmol. 1998;82:91–6.
10. Jiang H-R, Lumsden L, Forrester JV. Macrophages and dendritic cells in
IRBP-induced experimental autoimmune uveoretinitis in B10RIII mice. Invest
Ophthalmol Vis Sci. 1999;40:3177–85.
11. Kerr EC, Raveney BJE, Copland DA, Dick AD, Nicholson LB. Analysis of retinal
cellular infiltrate in experimental autoimmune uveoretinitis reveals multiple
regulatory cell populations. J Autoimmun. 2008;31:354–61.
12. Jung S, Aliberti J, Graemmel P, Sunshine MJ, Kreutzberg GW, Sher A, et al.
Analysis of fractalkine receptor CX3CR1 function by targeted deletion and green
fluorescent protein reporter gene insertion. Mol Cell Biol. 2000;20:4106–14.
13. Langmann T. Microglia activation in retinal degeneration. J Leukoc Biol.
2007;81:1345–51.
14. Lee JE, Liang KJ, Fariss RN, Wong WT. Ex vivo dynamic imaging of retinal
microglia using time-lapse confocal microscopy. Invest Ophthalmol Vis Sci.
2008;49:4169–76.
15. Liang KJ, Lee JE, Wang YD, Ma W, Fontainhas AM, Fariss RN, et al.
Regulation of dynamic behavior of retinal microglia by CX3CR1 signaling.
Invest Ophthalmol Vis Sci. 2009;50:4444–51.
16. Kezic JM, Chen X, Rakoczy EP, McMenamin PG. The effects of age and
Cx3cr1 deficiency on retinal microglia in the Ins2Akita diabetic mouse.
Invest Ophthalmol Vis Sci. 2013;54:854–63.
17. Karlstetter M, Ebert S, Langmann T. Microglia in the healthy and degenerating
retina: insights from novel mouse models. Immunobiology. 2010;215:685–91.
18. Liu Z, Condello C, Schain A, Harb R, Grutzendler J. CX3CR1 in microglia
regulates brain amyloid deposition through selective protofibrillar amyloid-β
phagocytosis. J Neurosci. 2010;30:17091–101.
19. Michaud J-P, Bellavance M-A, Préfontaine P, Rivest S. Real-time in vivo
imaging reveals the ability of monocytes to clear vascular amyloid beta. Cell
Reports. 2013;5:646–53.
20. Nimmerjahn A, Kirchhoff F, Helmchen F. Resting microglial cells are highly
dynamic surveillants of brain parenchyma in vivo. Science. 2005;308:1314–8.
Chen et al. Journal of Neuroinflammation  (2015) 12:17 Page 11 of 1221. Alt C, Runnels JM, Teo GSL, Lin PC. In vivo tracking of hematopoietic cells in
the retina of chimeric mice with a scanning laser ophthalmoscope.
IntraVital. 2012;1:132–40.
22. Chen X, Kezic J, Bernard C, McMenamin PG. Rd8 mutation in the Crb1 gene of
CD11c-eYFP transgenic reporter mice results in abnormal numbers of
CD11c-positive cells in the retina. J Neuropathol Exp Neurol. 2013;72:782–90.
23. Spencer D, Lee E, Kawaguchi T, Rosenbaum J. In vivo imaging of the
immune response in the eye. Semin Immunopathol. 2008;30:179–90.
24. Hume DA. Applications of myeloid-specific promoters in transgenic mice
support in vivo imaging and functional genomics but do not support the
concept of distinct macrophage and dendritic cell lineages or roles in
immunity. J Leukoc Biol. 2011;89:525–38.
25. Lindquist RL, Shakhar G, Dudziak D, Wardemann H, Eisenreich T, Dustin ML,
et al. Visualizing dendritic cell networks in vivo. Nat Immunol. 2004;5:1243–50.
26. Faust N, Varas F, Kelly LM, Heck S, Graf T. Insertion of enhanced green
fluorescent protein into the lysozyme gene creates mice with green
fluorescent granulocytes and macrophages. Blood. 2000;96:719–26.
27. Abramoff MD, Magelhaes PJ, Ram SJ. Image processing with ImageJ.
Biophotonics Int. 2004;11:36–42.
28. Dick AD, Cheng YF, Liversidge J, Forrester JV. Immunomodulation of
experimental autoimmune uveoretinitis: a model of tolerance induction
with retinal antigens. Eye. 1994;8:52–9.
29. Chan C-C, Caspi RR, Ni M, Leake WC, Wiggert B, Chader GJ, et al. Pathology of
experimental autoimmune uveoretinitis in mice. J Autoimmun. 1990;3:247–55.
30. Cortes LM, Mattapallil MJ, Silver PB, Donoso LA, Liou GI, Zhu W, et al.
Repertoire analysis and new pathogenic epitopes of IRBP in C57BL/6 (H-2b)
and B10.RIII (H-2r) mice. Invest Ophthalmol Vis Sci. 2008;49:1946–56.
31. Anandasabapathy N, Victora GD, Meredith M, Feder R, Dong B, Kluger C,
et al. Flt3L controls the development of radiosensitive dendritic cells in the
meninges and choroid plexus of the steady-state mouse brain. J Exp Med.
2011;208:1695–705.
32. Kaunzner UW, Miller MM, Gottfried-Blackmore A, Gal-Toth J, Felger JC,
McEwen BS, et al. Accumulation of resident and peripheral dendritic cells in
the aging CNS. Neurobiol Aging. 2012;33:681–93. e681.
33. Lee EJ, Rosenbaum JT, Planck SR. Epifluorescence intravital microscopy of
murine corneal dendritic cells. Invest Ophthalmol Vis Sci. 2010;51:2101–8.
34. Gelman AE, Li W, Richardson SB, Zinselmeyer BH, Lai J, Okazaki M, et al.
Cutting edge: acute lung allograft rejection is independent of secondary
lymphoid organs. J Immunol. 2009;182:3969–73.
35. Ng LG, Hsu A, Mandell MA, Roediger B, Hoeller C, Mrass P, et al. Migratory
dermal dendritic cells act as rapid sensors of protozoan parasites. PLoS
Pathog. 2008;4:e1000222.
36. McDole JR, Wheeler LW, McDonald KG, Wang B, Konjufca V, Knoop KA, et al.
Goblet cells deliver luminal antigen to CD103+ dendritic cells in the small
intestine. Nature. 2012;483:345–9.
37. Kreisel D, Nava RG, Li W, Zinselmeyer BH, Wang B, Lai J, et al. In vivo two-photon
imaging reveals monocyte-dependent neutrophil extravasation during
pulmonary inflammation. Proc Natl Acad Sci U S A. 2010;107:18073–8.
38. Germain RN, Miller MJ, Dustin ML, Nussenzweig MC. Dynamic imaging of
the immune system: progress, pitfalls and promise. Nat Rev Immunol.
2006;6:497–507.
39. Li JL, Goh CC, Keeble JL, Qin JS, Roediger B, Jain R, et al. Intravital
multiphoton imaging of immune responses in the mouse ear skin. Nat
Protocols. 2012;7:221–34.
40. Small DM, Sanchez WY, Roy S, Hickey MJ, Gobe GC. Multiphoton
fluorescence microscopy of the live kidney in health and disease. J Biomed
Opt. 2014;19:020901–1.
41. Grayson MH, Hotchkiss RS, Karl IE, Holtzman MJ, Chaplin DD. Intravital
microscopy comparing T lymphocyte trafficking to the spleen and
the mesenteric lymph node. Am J Physiol Heart Circ Physiol.
2003;284:H2213–26.
42. Gavins FNE, Chatterjee BE. Intravital microscopy for the study of mouse
microcirculation in anti-inflammatory drug research: focus on the mesentery
and cremaster preparations. J Pharmacol Toxicol Methods. 2004;49:1–14.
43. Devi S, Li A, Westhorpe CLV, Lo CY, Abeynaike LD, Snelgrove SL, et al.
Multiphoton imaging reveals a new leukocyte recruitment paradigm in the
glomerulus. Nat Med. 2013;19:107–12.
44. Norman MU, Van De Velde NC, Timoshanko JR, Issekutz A, Hickey MJ.
Overlapping roles of endothelial selectins and vascular cell adhesion
molecule-1 in immune complex-induced leukocyte recruitment in the
cremasteric microvasculature. Am J Pathol. 2003;163:1491–503.45. Wong J, Johnston B, Lee SS, Bullard DC, Smith CW, Beaudet AL, et al. A
minimal role for selectins in the recruitment of leukocytes into the inflamed
liver microvasculature. J Clin Invest. 1997;99:2782–90.
46. Sorg H, Krueger C, Vollmar B. Intravital insights in skin wound healing using
the mouse dorsal skin fold chamber. J Anat. 2007;211:810–8.
47. Pai S, Danne KJ, Qin J, Cavanagh LL, Smith A, Hickey MJ, et al. Visualising
leukocyte trafficking in the living brain with 2-photon intravital microscopy.
Front Cellular Neurosci. 2013;6(67):1–14.
48. Masedunskas A, Milberg O, Porat-Shliom N, Sramkova M, Wigand T,
Amornphimoltham P, et al. Intravital microscopy: A practical guide on imaging
intracellular structures in live animals. Bioarchitecture. 2012;2:143–57.
49. Camelo S, Shanley AC, Voon ASP, McMenamin PG. An intravital and confocal
microscopic study of the distribution of intracameral antigen in the aqueous
outflow pathways and limbus of the rat eye. Exp Eye Res. 2004;79:455–64.
50. Caspi RR, Roberge FG, Chan CC, Wiggert B, Chader GJ, Rozenszajn LA, et al.
A new model of autoimmune disease. Experimental autoimmune
uveoretinitis induced in mice with two different retinal antigens. J Immunol.
1988;140:1490–5.
51. Copland DA, Wertheim MS, Armitage WJ, Nicholson LB, Raveney BJE, Dick
AD. The clinical time-course of experimental autoimmune uveoretinitis
using topical endoscopic fundal imaging with histologic and cellular
infiltrate correlation. Invest Ophthalmol Vis Sci. 2008;49:5458–65.
52. Dagkalis A, Wallace C, Xu H, Liebau S, Manivannan A, Stone MA, et al.
Development of experimental autoimmune uveitis: efficient recruitment of
monocytes is independent of CCR2. Invest Ophthalmol Vis Sci. 2009;50:4288–94.
53. Chu CJ, Herrmann P, Carvalho LS, Liyanage SE, Bainbridge JWB, Ali RR, et al.
Assessment and in vivo scoring of murine experimental autoimmune
uveoretinitis using optical coherence tomography. PLoS ONE. 2013;8:e63002.
54. Gadjanski I, Williams SK, Hein K, Sättler MB, Bähr M, Diem R. Correlation of
optical coherence tomography with clinical and histopathological findings
in experimental autoimmune uveoretinitis. Exp Eye Res. 2011;93:82–90.
55. Chen J, Qian H, Horai R, Chan C-C, Caspi RR. Use of optical coherence
tomography and electroretinography to evaluate retinal pathology in a
mouse model of autoimmune uveitis. PLoS ONE. 2013;8:e63904.
56. Laliotou B, Dick AD. Modulating phenotype and cytokine production of
leucocytic retinal infiltrate in experimental autoimmune uveoretinitis
following intranasal tolerance induction with retinal antigens. Br J
Ophthalmol. 1999;83:478–85.
57. Thurau SR, Mempel TR, Flügel A, Diedrichs-Möhring M, Krombach F, Kawakami
N, et al. The fate of autoreactive, GFP+ T cells in rat models of uveitis analyzed
by intravital fluorescence microscopy and FACS. Int Immunol. 2004;16:1573–82.
58. Hamada M, Ogura Y, Miyamoto K, Nishiwaki H, Hiroshiba N, Honda Y.
Retinal leukocyte behavior in experimental autoimmune uveoretinitis of rats.
Exp Eye Res. 1997;65:445–50.
59. Parnaby-Price A, Stanford MR, Biggerstaff J, Howe L, Whiston RA, Marshall J,
et al. Leukocyte trafficking in experimental autoimmune uveitis in vivo. J
Leukoc Biol. 1998;64:434–40.
60. Vagaja NN, Chinnery HR, Binz N, Kezic JM, Rakoczy EP, McMenamin PG.
Changes in murine hyalocytes are valuable early indicators of ocular
disease. Invest Ophthalmol Vis Sci. 2012;53:1445–51.
61. Chinnery HR, McLenachan S, Humphries T, Kezic JM, Chen X, Ruitenberg MJ,
et al. Accumulation of murine subretinal macrophages: effects of age,
pigmentation and CX3CR1. Neurobiol Aging. 2011;33:1769–76.
62. Raoul W, Auvynet C, Camelo S, Guillonneau X, Feumi C, Combadiere C, et al.
CCL2/CCR2 and CX3CL1/CX3CR1 chemokine axes and their possible involvement
in age-related macular degeneration. J Neuroinflammation. 2010;7:87.
63. Luhmann UFO, Robbie S, Munro PMG, Barker SE, Duran Y, Luong V, et al.
The Drusenlike phenotype in aging Ccl2-knockout mice is caused by an
accelerated accumulation of swollen autofluorescent subretinal macrophages.
Invest Ophthalmol Vis Sci. 2009;50:5934–43.
64. Dick AD. Influence of microglia on retinal progenitor cell turnover and cell
replacement. Eye. 2008;23:1939–45.
65. Combadiere C, Feumi C, Raoul W, Keller N. Rod, Ro M, et al. CX3CR1-dependent
subretinal microglia cell accumulation is associated with cardinal features of
age-related macular degeneration. J Clin Invest. 2007;117:2920–8.
66. Zhao L, Ma W, Fariss RN, Wong WT. Retinal vascular repair and
neovascularization are not dependent on CX3CR1 signaling in a model of
ischemic retinopathy. Exp Eye Res. 2009;88:1004–13.
67. Fischer F, Martin G, Agostini H. Activation of retinal microglia rather than
microglial cell density correlates with retinal neovascularization in the mouse
model of oxygen-induced retinopathy. J Neuroinflammation. 2011;8:120.
Chen et al. Journal of Neuroinflammation  (2015) 12:17 Page 12 of 1268. Dagkalis A, Wallace C, Hing B, Liversidge J, Crane IJ. CX3CR1-deficiency is
associated with increased severity of disease in experimental autoimmune
uveitis. Immunology. 2009;128:25–33.
69. Jung S, Unutmaz D, Wong P, Sano GI, Delos Santos K, Sparwasser T, et al. In
vivo depletion of CD11c + dendritic cells abrogates priming of CD8+ T cells
by exogenous cell-associated antigens. Immunity. 2002;17:211–20.
70. Bulloch K, Miller MM, Gal-Toth J, Milner TA, Gottfried-Blackmore A, Waters
EM, et al. CD11c/EYFP transgene illuminates a discrete network of dendritic
cells within the embryonic, neonatal, adult, and injured mouse brain. J
Comp Neurol. 2008;508:687–710.
71. Mattapallil MJ, Wawrousek EF, Chan C-C, Zhao H, Roychoudhury J, Ferguson
TA, et al. The Rd8 mutation of the Crb1 gene is present in vendor lines of
C57BL/6 N mice and embryonic stem cells, and confounds ocular induced
mutant phenotypes. Invest Ophthalmol Vis Sci. 2012;53:2921–7.
72. Medina-Contreras O, Geem D, Laur O, Williams IR, Lira SA, Nusrat A, et al.
CX3CR1 regulates intestinal macrophage homeostasis, bacterial
translocation, and colitogenic Th17 responses in mice. J Clin Invest.
2011;121:4787–95.
73. Kim K-W, Vallon-Eberhard A, Zigmond E, Farache J, Shezen E, Shakhar G,
et al. In vivo structure/function and expression analysis of the CX3C
chemokine fractalkine. Blood. 2011;118:e156–e167.
74. Hochheiser K, Heuser C, Krause TA, Teteris S, Ilias A, Weisheit C, et al.
Exclusive CX3CR1 dependence of kidney DCs impacts glomerulonephritis
progression. J Clin Invest. 2013;123:4242–54.
75. Lionakis MS, Swamydas M, Fischer BG, Plantinga TS, Johnson MD, Jaeger M,
et al. CX3CR1-dependent renal macrophage survival promotes Candida
control and host survival. J Clin Invest. 2013;123:5035–51.
76. Huang D, Shi F-D, Jung S, Pien GC, Wang J, Salazar-Mather TP, et al. The
neuronal chemokine CX3CL1/fractalkine selectively recruits NK cells that
modify experimental autoimmune encephalomyelitis within the central
nervous system. FASEB J. 2006;20:896–905.
77. Ueno M, Fujita Y, Tanaka T, Nakamura Y, Kikuta J, Ishii M, et al. Layer V
cortical neurons require microglial support for survival during postnatal
development. Nat Neurosci. 2013;16:543–51.
78. Kezic J, Xu H, Chinnery HR, Murphy CC, McMenamin PG. Retinal microglia
and uveal tract dendritic cells and macrophages are not CX3CR1
dependent in their recruitment and distribution in the young mouse eye.
Invest Ophthalmol Vis Sci. 2008;49:1599–608.
79. Singh-Jasuja H, Thiolat A, Ribon M, Boissier M-C, Bessis N, Rammensee H-G, et al.
The mouse dendritic cell marker CD11c is down-regulated upon cell activation
through Toll-like receptor triggering. Immunobiology. 2013;218:28–39.
80. Felger JC, Abe T, Kaunzner UW, Gottfried-Blackmore A, Gal-Toth J, McEwen
BS, et al. Brain dendritic cells in ischemic stroke: time course, activation state,
and origin. Brain Behav Immun. 2010;24:724–37.
81. Lin A, Loughman JA, Zinselmeyer BH, Miller MJ, Caparon MG. Streptolysin S
inhibits neutrophil recruitment during the early stages of streptococcus
pyogenes infection. Infect Immun. 2009;77:5190–201.
82. Howe C, LaFrance-Corey R, Sundsbak R, LaFrance S. Inflammatory monocytes
damage the hippocampus during acute picornavirus infection of the brain.
J Neuroinflammation. 2012;9:50.
83. Byrne R, Rath E, Hladik A, Niederreiter B, Bonelli M, Frantal S, et al. A dynamic
real time in vivo and static ex vivo analysis of granulomonocytic cell migration
in the collagen-induced arthritis model. PLoS ONE. 2012;7:e35194.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
